Condition

Diabetic Kidney Disease (DKD)

ClinicalTrials.gov condition label

Clinical trials18
Recruiting4
Common interventions25
Lead sponsors shown15

Clinical trials

18 shown
Goal-Directed Therapy to Reduce Kidney and Cardiovascular Risk in Diabetic Kidney Disease (GOLD-STANDARD)NCT07434791 · 2026-08-26
RECRUITING
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney DiseaseNCT07271186 · 2026-01-09
RECRUITING
Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney DiseaseNCT06969807 · 2025-06-09
RECRUITING
Efficacy and Safety Study of Isuzinaxib in Subjects With DKDNCT06962098 · 2025-05-26
RECRUITING
The Relationship Between Psychological Well-being, Social Support, and Disease Self-management in Patients With Diabetic NephropathyNCT07726589 · 2026-08-07
NOT_YET_RECRUITING
Mechanisms Underlying SGLT2i Kidney Effect in DKD ProgressionNCT07270198 · 2026-02-01
NOT_YET_RECRUITING
Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart FailureNCT07326631 · 2026-01-01
NOT_YET_RECRUITING
Mesenchymal Stem Cells for Chronic Kidney DiseasesNCT07240987 · 2026-01-01
NOT_YET_RECRUITING
Rubix LS Diabetic Kidney Disease (DKD) Registry StudyNCT07348718 · 2025-12-15
ACTIVE_NOT_RECRUITING
YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study2NCT07034807 · 2025-08-01
NOT_YET_RECRUITING
YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1NCT07032116 · 2025-08-01
NOT_YET_RECRUITING
Remote Ischemic Conditioning for the Treatment of Diabetic Kidney DiseaseNCT06654921 · 2025-01-01
NOT_YET_RECRUITING
Safety and Efficacy of the Combination Therapy of Fucoidan / Fucoxanthin / L-carnitine in Patients With Diabetic Nephropathy.NCT07804641 · 2024-11-06
COMPLETED
Preliminary Study of CXCL3 As a Biomarker of Diabetic Kidney DiseaseNCT06639529 · 2024-06-10
COMPLETED
Autologous Dendritic Cell as Adjunct Therapy for Diabetic Kidney DiseaseNCT06866158 · 2024-05-01
ACTIVE_NOT_RECRUITING
ALLOPURINOL AND LISINOPRIL FOR DIABETIC KIDNEY PROTECTION: A COMPARATIVE STUDY IN NORMOURICEMIC TYPE 2 DIABETICSNCT07177898 · 2023-05-14
COMPLETED
Establishment of the Human Intestinal and Salivary Microbiota Biobank - Kidney DiseasesNCT04689074 · 2021-02-03
COMPLETED
Vascular Endothelial Growth Factor-B (VEGF-B) Blockade With the Monoclonal Antibody CSL346 in Subjects With Diabetic Kidney DiseaseNCT04419467 · 2020-09-14
COMPLETED

Common interventions

PlaceboDRUG30.9% sodium chlorideDRUG1AllopurinolDRUG1ALN-ANG3DRUG1AmimestrocelDRUG1basic treatmentCOMBINATION_PRODUCT1Biological sample collectionOTHER1CSL346BIOLOGICAL1Dendritic cell immunotherapyBIOLOGICAL1Early goal-directed Cardio-Kidney-Metabolic (CKM) careOTHER1EvinacumabDRUG1FinerenoneDRUG1IsuzinaxibDRUG1Kidney-Protective Therapies Used in Routine CareDRUG1Medical examinationOTHER1MRIPROCEDURE1MSCsDRUG1Oligo-fucoidan, Fucoxanthin, L-carnitine Formula, Zinc yeast (FFL)DIETARY_SUPPLEMENT1QuestionnaireOTHER1Remote ischemic conditioningDEVICE1Sham remote ischemic conditioningDEVICE1Standard care (Comparison arm)OTHER1Standard medication therapyDRUG1Tests of the expression of CXCL3 in various tissuesDIAGNOSTIC_TEST1the traditional Chinese medicine prescription ' Shenzhuo Decoction 'DRUG1

Trial status mix

NOT_YET_RECRUITING7
COMPLETED5
RECRUITING4
ACTIVE_NOT_RECRUITING2

Phase mix

NA7
PHASE27
PHASE12

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.